Statistics

Total Visits

Views
Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: Final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial21

Select a period of time:

Number of views in the range

Views
Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: Final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial10

Views

Views
May 20241
June 20240
July 20241
August 20243
September 20242
October 20242
November 20241
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
 

Top cities views

Views